MedTrace Logo

Ex-Vivo Lung Perfusion to Increase the Number of Organs for Transplantation

NCT01967953 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2013-10-23

No results posted yet for this study

Summary

The recent introduction of ex-vivo lung perfusion (EVLP) as a tool to evaluate and recondition lungs from marginal donors has opened a new era in the field of lung transplantation.

Conditions

  • Disorder Related to Lung Transplantation
  • Brain Death
  • Graft Failure
  • Primary Graft Dysfunction

Interventions

PROCEDURE

EVLP Group

EVLP technique: Steen solution; normothermia; low flow, open atrium, low hematocrit. Endpoints of EVLP assessment of lungs suitability: oxygenation, respiratory mechanics, pulmonary vascular resistance, chest X-ray, fibrobronchoscopy

Sponsors & Collaborators

  • Policlinico Hospital

    lead OTHER

Principal Investigators

  • Franco Valenza, MD · Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico Milan Italy

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01967953 on ClinicalTrials.gov